Unlearn Stock

unlearn.aiHealthcareFounded: 2017Funding to Date: $85.17MM

Unlearn.AI is an AI healthcare company specializing in creating digital twins of patients to conduct clinical studies. Their technology aims to estimate the effects of therapy options for those affected by disease. Unlearn.AI was founded in 2017 by Charles Fisher Ph.D., Jonathan Walsh Ph.D., Aaron Smith Ph.D., and Graham Siegel JD and is headquartered in San Francisco, CA.

Register for Details

For more details on financing and valuation for Unlearn, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Unlearn.

Register Today

Team

Management Team

Charles Fisher Ph.D
Co-Founder, Chief Executive Officer, President & Board Member
Dave Miller
Chief Science Officer
Jonathan Walsh Ph.D
Co-Founder & Head of Data Science
Aaron Smith Ph.D
Co-Founder, Head of Machine Learning & Board Member

Board Members

Alaa Halawa
Mubadala Capital-Ventures
Dylan Morris Ph.D
Insight Partners
Francisco Gimenez Ph.D
8VC
John Hamer Ph.D
DCVC

Other companies like Unlearn in the Healthcare sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$809.52MM
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$396.01MM
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$1.53B

News

Unlearn.AI, which has built a machine learning platform that creates "digital twin" profiles of patients in clinical trials, has raised $15 million to expand partnerships and accelerate regulatory approval, the company told Reuters on Tuesday.
Unlearn, which uses artificial intelligence to speed clinical trials, recently began offering new hires multiple pay options. It’s among a growing number of companies that let new hires customize their compensation with different combinations of salary, equity and, in some cases, benefits.
Now, using machine learning and generative AI, a startup called Unlearn.ai is aiming to transform clinical trials by tackling one of its biggest challenges: recruiting enough people to participate. Its solution? Digital twins.